CXMT's Shanghai debut puts a thin-float price on China's memory bet

Jing Jie Yu, a Morningstar equity analyst, said the offering had been priced at roughly one times Morningstar's estimated 2027 price-to-book value, compared with 2.1 to 2.3 times for global peers. That is a comparison of the offering's pricing against an analyst's forward estimate—not a like-for-like comparison of CXMT's closing valuation with those companies. Yu nevertheless called the first-day move excessive, citing the cyclicality of memory and the longer-term effect of export controls on access to advanced technology.

What the financing changes—and what it does not

CXMT raised 57.92 billion yuan ($8.6 billion), the largest mainland Chinese semiconductor offering on record, the Reuters report said. It exceeded SMIC's $7.5 billion Shanghai share sale in 2020 on that semiconductor-specific comparison; the proceeds could rise to 66.61 billion yuan if an over-allotment option is fully used. On the broader mainland IPO comparison, an account of the listing described it as second only to Agricultural Bank of China's $22.1 billion Shanghai-and-Hong Kong offering in 2010.

The capital arrives as the company reports fast growth. CXMT's first-quarter revenue reached 50.8 billion yuan ($7.5 billion), more than seven times the year-earlier period, the report said. Separately, CXMT expects first-half revenue of 110 billion to 120 billion yuan and net profit of 66 billion to 75 billion yuan, reversing a year-earlier loss. Those are the company's projections, reported by Reuters, rather than reported results.

Kyle Chan, a Brookings Institution fellow who studies China's technology policy, said CXMT has a critical role in China's AI push under U.S. export controls. The constraint is not simply the availability of money: Chan said the company has highly restricted access to the world's most advanced chipmaking tools and must rely on Chinese equipment makers as it expands, according to the report.

Demand is an opportunity, not a verdict on competitiveness

The market backdrop is unusually favourable. Ellie Wang, an analyst at technology-research firm TrendForce, said memory prices were expected to keep rising through the end of 2027 and that supply shortages could encourage customers to diversify their suppliers. That is an analyst forecast about the market, not evidence that CXMT has already won the resulting business.

CXMT itself said in its prospectus that AI demand had driven the latest memory upswing, but warned the market could weaken if AI investment slowed or competitors added too much supply, as the Reuters report reported. The company may be strategically important to China's domestic supply ambitions while still being exposed to the same demand cycle it is benefiting from.

The valuation also should not be mistaken for a product comparison. CXMT is China's largest memory-chip maker, but its market capitalisation remains below those of Samsung Electronics, SK Hynix and Micron Technology, according to the AP comparison. Market value is not manufacturing capability, but neither does CXMT's one-day price establish parity with those suppliers.

The evidence investors still need

The next test is operational rather than ceremonial: whether CXMT's reported revenue growth and first-half forecasts translate into sustained production and profits while it works around equipment restrictions. The source record establishes a large DRAM business, China's restricted access to imported HBM and a sizeable new pool of capital; it does not establish how much advanced memory CXMT can reliably make and supply at scale.

That is the evidence needed to turn a strategically significant listing into a durable competitive claim. Until then, the debut is a clear signal of investor demand for a Chinese memory champion, but an incomplete answer to the question of how far that champion can close the technology and supply gap.